Laddar...
Recombinant erythropoietin in clinical practice
The introduction of recombinant human erythropoietin (RHuEPO) has revolutionised the treatment of patients with anaemia of chronic renal disease. Clinical studies have demonstrated that RHuEPO is also useful in various non-uraemic conditions including haematological and oncological disorders, premat...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BMJ Group
2003
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1742767/ https://ncbi.nlm.nih.gov/pubmed/12897214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/pmj.79.933.367 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|